Are you wondering what Rinvoq is and how it works for psoriasis-related conditions? Here's a helpful overview!
Rinvoq (upadacitinib) is an oral medication approved by the FDA to treat active psoriatic arthritis (PsA), particularly for adults who haven't found relief from other treatments. It belongs to a class of drugs Show Full Answer
Are you wondering what Rinvoq is and how it works for psoriasis-related conditions? Here's a helpful overview!
Rinvoq (upadacitinib) is an oral medication approved by the FDA to treat active psoriatic arthritis (PsA), particularly for adults who haven't found relief from other treatments. It belongs to a class of drugs called JAK inhibitors (Janus kinase inhibitors). How It Works
Rinvoq targets specific JAK proteins that send inflammatory signals in the body. Rather than broadly suppressing the immune system, it zeroes in on these specific pathways to reduce inflammation.
It comes as a once-daily 15mg extended-release tablet that can be taken with or without food — no injections needed! What It Can Help With
Studies have shown Rinvoq can improve:
- Joint symptom relief
- Skin clearance
- Physical function
- Fatigue Important Risks to Know
The FDA has issued warnings for JAK inhibitors like Rinvoq. Serious potential risks include:
- Stroke or heart attack
- Blood clots
- Certain cancers (lymphoma, skin cancer, lung cancer)
- Increased vulnerability to infections
It's really important to discuss these risks thoroughly with a doctor before starting Rinvoq. Cost Assistance
Rinvoq can be expensive, but AbbVie offers a copay savings program called Rinvoq Complete that may help reduce out-of-pocket costs for eligible individuals on private insurance.
May 25
Join
Your Privacy Choices
